Imunon, Inc. — Director's Dealing 2011

Mar 1, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-02-25

Reporting Person: Tardugno Michael H (CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-25	Option to purchase common stock	$2.49	A	180000	Acquired	2021-02-25	Celsion Corporation Common Stock (180000)	Direct

Footnotes

F1: Options to purchase shares of Celsion Corporation Common Stock vest in thirds over three years, with the first vesting date on February 25, 2012 and annually thereafter.

F2: Closing price of Celsion Corporation Common Stock on date of award.